Related references
Note: Only part of the references are listed.The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: A tribute to the late Dr. Yoshio Watanabe
Masashi Shiomi et al.
ATHEROSCLEROSIS (2009)
Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome
Hiromasa Otake et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions
M. Shiomi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Intensive Statin Therapy in Acute Coronary Syndromes
Tze Vun Liew et al.
CURRENT ATHEROSCLEROSIS REPORTS (2008)
Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries
Masashi Shiomi et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Renin inhibitor aliskiren improves impaired nitric oxide Bioavailability and protects against atherosclerotic changes
Toshio Imanishi et al.
HYPERTENSION (2008)
Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits
Toshio Imanishi et al.
HYPERTENSION RESEARCH (2008)
High-resolution three-dimensional aortic magnetic resonance angiography and quantitative vessel wall characterization of different atherosclerotic stages in a rabbit model
Henning Steen et al.
INVESTIGATIVE RADIOLOGY (2007)
Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M
Joerg Meding et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2007)
Executive summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2007)
Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary plaque-prone WHHL rabbits
M Shiomi et al.
ATHEROSCLEROSIS (2005)
In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave
G Liu et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Progression of coronary atherosclerosis relates to the onset of myocardial infarction in an animal model of spontaneous myocardial intarction (WHHLMI rabbits)
T Ito et al.
EXPERIMENTAL ANIMALS (2004)
Transgenic rabbits as therapeutic protein bioreactors and human disease models
JL Fan et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit)
M Shiomi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits
N Yoshida et al.
ATHEROSCLEROSIS (2002)
MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion
M Shiomi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins
M Shiomi et al.
ATHEROSCLEROSIS (2001)
Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits -: Protective effects of vitamin E
F de Nigris et al.
CIRCULATION (2000)
Age-associated decrease in plasma cholesterol and changes in cholesterol metabolism in homozygous watanabe heritable hyperlipidemic rabbits
M Shiomi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Share Paper
